Syngene International Limited has announced a conference call for analysts and investors to discuss its Q4 and full year FY2026 financial results. The call is scheduled for Thursday, April 30, 2026, at 2:00 PM IST, following the company's quarterly earnings announcement.

Conference Call Details

The management team will conduct a comprehensive session covering the company's performance for the quarter and full year ended March 2026. The call format includes an initial management discussion followed by an interactive Question & Answer session.

Access Options and International Participation

The company has arranged multiple access channels to accommodate global participation. International dial-in numbers are available for various regions including the USA (18667462133), UK (08081011573), Singapore (8001012045), Hong Kong (800964448), and Australia (0080014243444).

Participants can utilize the Diamond Pass™ pre-registration facility by registering in advance to receive a passcode and pin for direct call access. The company recommends dialing in 10 minutes prior to the scheduled time to ensure proper connection.

Replay and Documentation

The audio recording will be available on the company's corporate website at https://syngeneintl.com/ alongside the call transcript for future reference.

Regulatory Compliance

This announcement has been made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was signed by Chethan Yogesh, Company Secretary & Compliance Officer, and communicated to both BSE Limited and National Stock Exchange of India Limited on April 22, 2026.

Syngene International Limited has formally notified the stock exchanges about an upcoming board meeting scheduled to review its financial performance and consider dividend distribution for shareholders.

Board Meeting Details

The company has announced that its Board of Directors will convene on Wednesday, April 29, 2026, to undertake several key agenda items. The meeting has been scheduled in compliance with Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Agenda Items

The board will consider and approve the audited standalone and consolidated financial results for the quarter and year ending March 31, 2026. Additionally, the directors will deliberate on the recommendation of final dividend, if any, amongst other routine matters that typically form part of such meetings.

Trading Window Restrictions

In accordance with regulatory compliance, the company has implemented mandatory trading restrictions for insiders. The trading window for dealing in securities has been closed from April 01, 2026, and will remain shut until the close of trading hours on May 01, 2026.

This closure period extends until 48 hours after the declaration of financial results, ensuring compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as well as the company's internal code of conduct for Prevention of Insider Trading.

Investor Engagement

Syngene International will organize a conference call for analysts and investors on Thursday, April 30, 2026, following the board meeting. The company has indicated that detailed information regarding the conference call will be made available on its official website closer to the scheduled event, allowing stakeholders to participate in the earnings discussion and seek clarifications on the financial performance.